Epsilon M&A Deal Report - Hermitage Genetics Designated Activity Company
Transaction Multiples for the Valuation of Private Companies
Genus / Hermitage Genetics Designated Activity Company
No EMAT :
116100
Announced Date :
23/02/2017
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Genus
Target :
Hermitage Genetics Designated Activity Company
Country :
Ireland
Sector of activity :
- Health, Pharmaceuticals & Biotechnology > Biotechnology
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Veterinary Pharmaceuticals
Business Description :
Hermitage Genetics Designated Activity Company includes technology being the genetic rights and intellectual property of Hermitage (porcine breeding and genetics company). > The prinicpal activity...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biotechnology » = 42
- Number of EMAT Reports / sub-sector « Veterinary Pharmaceuticals » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 13/03/2024 | Advanced Medical Solutions Group | Peters Surgical | Hauts-De-Seine | *** | 116034 |
| 04/03/2024 | Halma | Rovers Medical Devices | Netherlands | ** | 115901 |
Source: Epsilon Research / EMAT
